axl bemcentinib (MedChemExpress)
Structured Review
Axl Bemcentinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 91 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/axl+bemcentinib/Bemcentinib/pmc13091335-23-42-44
Average 96 stars, based on 91 article reviews
Images
Related Articles
other:Article Title: LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance. Article Snippet: For pharmacological studies, cells were treated with inhibitors to various kinases, including BCR-ABL: imatinib (S2475), dasatinib (S1021), or ponatinib (S1490); AKT: AKTi-1/2 (S7776); mTOR: rapamycin (Cayman, 13346); PKC/FLT3: midostaurin (S8064); SGK: GSK650394 (S7209); PDK1: BX-912 (Cayman, 14708; CaMKII: KN-93 (Cayman, 21472); or Article Title: LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance Article Snippet: For pharmacological studies, cells were treated with inhibitors to various kinases, including BCR-ABL: imatinib (S2475), dasatinib (S1021), or ponatinib (S1490); AKT: AKTi-1/2 (S7776); mTOR: rapamycin (Cayman, 13346); PKC/FLT3: midostaurin (S8064); SGK: GSK650394 (S7209); PDK1: BX-912 (Cayman, 14708; CaMKII: KN-93 (Cayman, 21472); or Article Title: LIN28A-Dependent Kinome and Phosphoproteome Reprogramming Promotes Imatinib Resistance Article Snippet: For pharmacological studies, cells were treated with inhibitors to various kinases, including BCR-ABL: imatinib (S2475), dasatinib (S1021), or ponatinib (S1490); AKT: AKTi-1/2 (S7776); mTOR: rapamycin (Cayman, 13346); PKC/FLT3: midostaurin (S8064); SGK: GSK650394 (S7209); PDK1: BX-912 (Cayman, 14708; CaMKII: KN-93 (Cayman, 21472); or |

